Whittier Trust’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.5K | Buy |
69
+33
| +92% | +$10.8K | ﹤0.01% | 1084 |
|
|
2025
Q1 | $9.72K | Hold |
36
| – | – | ﹤0.01% | 1217 |
|
|
2024
Q4 | $8.47K | Hold |
36
| – | – | ﹤0.01% | 1277 |
|
|
2024
Q3 | $9.9K | Hold |
36
| – | – | ﹤0.01% | 1264 |
|
|
2024
Q2 | $8.75K | Hold |
36
| – | – | ﹤0.01% | 1265 |
|
|
2024
Q1 | $5.38K | Sell |
36
-1
| -3% | -$149 | ﹤0.01% | 1347 |
|
|
2023
Q4 | $7.08K | Sell |
37
-1
| -3% | -$191 | ﹤0.01% | 1274 |
|
|
2023
Q3 | $6.73K | Buy |
38
+2
| +6% | +$354 | ﹤0.01% | 1325 |
|
|
2023
Q2 | $6.84K | Hold |
36
| – | – | ﹤0.01% | 1322 |
|
|
2023
Q1 | $7.21K | Sell |
36
-6
| -14% | -$1.2K | ﹤0.01% | 1350 |
|
|
2022
Q4 | $9.98K | Buy |
42
+6
| +17% | +$1.43K | ﹤0.01% | 1289 |
|
|
2022
Q3 | $7K | Hold |
36
| – | – | ﹤0.01% | 1387 |
|
|
2022
Q2 | $5K | Hold |
36
| – | – | ﹤0.01% | 1427 |
|
|
2022
Q1 | $6K | Hold |
36
| – | – | ﹤0.01% | 1414 |
|
|
2021
Q4 | $6K | Hold |
36
| – | – | ﹤0.01% | 1379 |
|
|
2021
Q3 | $7K | Hold |
36
| – | – | ﹤0.01% | 1287 |
|
|
2021
Q2 | $6K | Hold |
36
| – | – | ﹤0.01% | 1332 |
|
|
2021
Q1 | $5K | Hold |
36
| – | – | ﹤0.01% | 1344 |
|
|
2020
Q4 | $5K | Hold |
36
| – | – | ﹤0.01% | 1232 |
|
|
2020
Q3 | $5K | Hold |
36
| – | – | ﹤0.01% | 1216 |
|
|
2020
Q2 | $5K | Hold |
36
| – | – | ﹤0.01% | 1157 |
|
|
2020
Q1 | $4K | Sell |
36
-28
| -44% | -$3.11K | ﹤0.01% | 1234 |
|
|
2019
Q4 | $7K | Buy |
64
+28
| +78% | +$3.06K | ﹤0.01% | 1181 |
|
|
2019
Q3 | $3K | Buy |
+36
| New | +$3K | ﹤0.01% | 1314 |
|